Author

R. M. Krug

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 2 Ecology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:benchmarking· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1 Approach:simulation· 1

Frequent Co-Authors

G. T. Montelione· 2 shared A. Garcia-Sastre· 1 shared B. Harish· 1 shared B. Schweibenz· 1 shared B. Shurina· 1 shared C. A. Royer· 1 shared C. Zhao· 1 shared E. Moreno· 1 shared

Activity by Year

2020-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

G. T. Montelione

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

The NS1 protein of influenza B virus binds 5'-triphosphorylated dsRNA to suppress RIG-I activation and the antiviral innate immune response

R. Woltz, B. Schweibenz, S. E. Tsutakawa, C. Zhao, L.-C. Ma, B. Shurina, G. L. Hura, R. John, S. Vorobiev, S. Gurla, M. Solotchi, J. A. Tainer, R. M. Krug, S. S. Patel, G. T. Montelione

bioRxiv · Sep 25, 2023 · PreprintBiochemistry

Microxanox: an R package for simulating an aquatic MICRobial ecosystem that can occupy OXic or ANOXic states

R. M. Krug, O. Petchey

Microxanox simulates an aquatic microbial ecosystem with three functional groups and four substrates using ODEs, allowing for parameter sweeps and stable state analysis.

bioRxiv · Feb 6, 2023 · PreprintEcology

Hepatitis C Virus Drugs Simeprevir and Grazoprevir Synergize with Remdesivir to Suppress SARS-CoV-2 Replication in Cell Culture

K. Bafna, K. White, B. Harish, R. Rosales, T. A. Ramelot, T. B. Acton, E. Moreno, T. Kehrer, C. A. Royer, A. Garcia-Sastre, R. M. Krug, G. T. Montelione

This paper evaluates HCV protease inhibitors as potential SARS-CoV-2 antivirals, finding that simeprevir and grazoprevir synergize with remdesivir to enhance antiviral activity against SARS-CoV-2 in cell culture.

bioRxiv · Dec 13, 2020Biochemistry